By Tom Buis, Global Health Advocate at Wemos Now more than ever is the time to advocate together for structural solutions to achieve equitable access to medical products. In the upcoming months, member states of the World Health Organization (WHO) will start the...
By Stephanie Kohl, Policy & Advocacy Officer at the European Association of Hospital Pharmacists (EAHP) Providing equal and timely access for all patients, including those with rare conditions and unmet needs, to all relevant medicinal therapies is one of the...
By Dr Ward Rommel, Chair, Access to Medicines Task Force, Association of European Cancer Leagues (ECL) – @CancerLeagues & @WardRommel | #LetsTalkAccess If you have cancer and you need medicine, you should be able to get it. Everyone agrees but, sadly,...
In June 2022, the members of the European Alliance for Responsible R&D and Affordable Medicines gathered in Rome to analyse the current public health scene and discuss potential solutions to the most prominent challenges. In light of public health outbreaks in the...
As the COVID pandemic started, expectations in the “access to medicines” community raised. After all, if a pandemic could not build the case for equitable access to vaccines and medicines, what would? Yet, initial promises, such as Von der Leyen’s commitment to...
